Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a background update to the site or content-management system.
    Difference
    0.0%
    Check dated 2026-09-03T18:21:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    An NIH grant/contract line for 2019 was added, and a new publication citation (Regnault et al., 2024) regarding tolerability in LIBRETTO-531 was also added.
    Difference
    0.0%
    Check dated 2026-08-27T15:50:48.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    A new Revision: v3.6.5 was added and the previous Revision: v3.6.4 was removed, indicating a minor update to the page's version metadata.
    Difference
    0.0%
    Check dated 2026-08-13T11:39:17.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a small frontend update to the study details page. This change does not modify study content or data.
    Difference
    0.0%
    Check dated 2026-07-23T08:37:38.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page shows a new revision tag: v3.6.3, replacing the previous v3.6.1. This indicates a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-07-02T03:20:33.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.6.1 is now displayed, replacing the previous v3.6.0. This reflects a frontend version update and does not modify study details or content on the page.
    Difference
    0.0%
    Check dated 2026-06-25T00:15:39.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.